Warm Autoimmune Hemolytic Anemia
📧 Sign up to get email alerts when something new happens for Warm Autoimmune Hemolytic Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab [Phase 2]
Phase 2 clinical trial evaluating Ianalumab in adults with primary immune thrombocytopenia and warm autoimmune hemolytic anemia who previous…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia [Phase 3]
A Phase 3 trial evaluating the efficacy, safety, and pharmacokinetics of oral rilzabrutinib versus placebo in adults with warm autoimmune he…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia [Phase 2, Phase 3]
HMPL-523 (Sovleplenib) is being studied for warm autoimmune hemolytic anemia in Phase 2 and Phase 3, and the trial is currently active but n…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Sirolimus in the Treatment of Refractory/Relapsed wAIHA [NA]
Sirolimus is being studied for refractory/relapsed warm autoimmune hemolytic anemia, and the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias [Phase 1, Phase 2]
Open-label Phase 1/2 study evaluating povetacicept in autoimmune cytopenias. The study includes immune thrombocytopenia and idiopathic throm…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA [Phase 2]
Phase 2 trial update evaluating zanubrutinib for relapsed/refractory warm autoimmune hemolytic anemia (wAIHA) with recruitment currently ong…